bHLH-PAS proteins in cancer
The DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Mammalian basic HLH (helix-loop-helix)-PER-ARNT-SIM (bHLH-PAS) proteins are heterodimeric transcription factors that sense and respond to environmental signals (such as pollutants) or to physiological signals (for example, hypoxia and circadian rhythms) through their two PAS domains. PAS domains form a generic three-dimensional fold, which commonly contains an internal cavity capable of small-molecule binding and outer surfaces adept at protein-protein interactions. These proteins are important in several pro-tumour and antitumour pathways and their activities can be modulated by both natural metabolites and oncometabolites. Recently determined structures and successful small-molecule screening programmes are now providing new opportunities to discover selective agonists and antagonists directed against this multitasking family of transcription factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Each HIF transcription factor is composed of two subunits: the α-subunit and the β-subunit, both of which belong to the basic helix-loop-helix (HLH)-PER-ARNT-SIM (bHLH-PAS) protein family (Bersten et al., 2013).”
From Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer (2016) · cites this paper as Bersten et al., 2013
In the citing paper
“The reliability of the model derived from this template is supported by the observation that the PAS fold is highly conserved, especially among the bHLH-PAS proteins which also share functional similarities2,33 (RMSD on Cα lower than 2 Å even between PAS domain pairs with 20–30% identity).”
From Modeling the binding of diverse ligands within the Ah receptor ligand binding domain (2019) · cites this paper as [2]
Citations
Cites
1 retracted
RETRACTED: Acriflavine inhibits HIF-1 dimerization, tumor growth, and vascularization
Lee, K., Zhang, H., Qian, D. Z., Rey, S., Liu, J. O., & Semenza, G. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909353106 · Cited by 451
RetractedThe Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Vogelstein, B., Papadopoulos, N., Velculescu, V. E., Zhou, S., Diaz, L. A., & Kinzler, K. W. (2013) · Science · doi:10.1126/science.1235122 · Cited by 7,863
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Integrative Genomic Profiling of Human Prostate Cancer
Taylor, B. S., Schultz, N., Hieronymus, H., Gopalan, A., Xiao, Y., Carver, B. S., Arora, V. K., Kaushik, P., Cerami, E., Reva, B., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.05.026 · Cited by 3,701
Hypoxia-inducible factors in physiology and medicine
Semenza, G. L. (2012) · Cell · doi:10.1016/j.cell.2012.01.021 · Cited by 3,645
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
A conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Cited by
Aryl hydrocarbon receptor ligands in cancer: friend and foe
Murray, I. A., Patterson, A. D., & Perdew, G. H. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3846 · Cited by 883
Therapeutic targeting of hypoxia and hypoxia-inducible factors in cancer
Wigerup, C., Påhlman, S., & Bexell, D. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2016.04.009 · Cited by 687
Indole and Tryptophan Metabolism: Endogenous and Dietary Routes to Ah Receptor Activation
Hubbard, T. D., Murray, I. A., & Perdew, G. H. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064246 · Cited by 640
Peek, C. B., Levine, D. C., Cedernaes, J., Taguchi, A., Kobayashi, Y., Tsai, S. J., Bonar, N. A., McNulty, M. R., Ramsey, K. M., & Bass, J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.010 · Cited by 409
The role of hypoxia-inducible factors in metabolic diseases
Gonzalez, F. J., Xie, C., & Jiang, C. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0096-z · Cited by 407
AHR in the intestinal microenvironment: safeguarding barrier function
Stockinger, B., Shah, K., & Wincent, E. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00430-8 · Cited by 403
Structural integration in hypoxia-inducible factors
Wu, D., Potluri, N., Lu, J., Kim, Y., & Rastinejad, F. (2015) · Nature · doi:10.1038/nature14883 · Cited by 346
MYC promotes tryptophan uptake and metabolism by the kynurenine pathway in colon cancer
Venkateswaran, N., Lafita-Navarro, M. C., Hao, Y.-H., Kilgore, J. A., Perez-Castro, L., Braverman, J., Borenstein-Auerbach, N., Kim, M., Lesner, N. P., Mishra, P., et al. (2019) · Genes & Development · doi:10.1101/gad.327056.119 · Cited by 252
New Trends in Aryl Hydrocarbon Receptor Biology
Mulero-Navarro, S., & Fernandez-Salguero, P. M. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00045 · Cited by 250
Impacts of microbiome metabolites on immune regulation and autoimmunity
Haase, S., Haghikia, A., Wilck, N., Müller, D. N., & Linker, R. A. (2018) · Immunology · doi:10.1111/imm.12933 · Cited by 239
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
Guerra, B., Recio, C., Aranda-Tavío, H., Guerra-Rodríguez, M., García-Castellano, J. M., & Fernández-Pérez, L. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.626971 · Cited by 157
The aryl hydrocarbon receptor as a mediator of host-microbiota interplay
Dong, F., & Perdew, G. H. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1859812 · Cited by 183
The Aryl Hydrocarbon Receptor and Tumor Immunity
Xue, P., Fu, J., & Zhou, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00286 · Cited by 160
Mescher, M., & Haarmann‐Stemmann, T. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.02.012 · Cited by 143
The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair
Shafi, A. A., McNair, C. M., McCann, J. J., Alshalalfa, M., Shostak, A., Severson, T., Zhu, Y., Bergman, A. M., Gordon, N., Mandigo, A. C., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20513-5 · Cited by 143
Mandl, M., & Depping, R. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00032 · Cited by 139
Vogel, C. F. A., & Haarmann‐Stemmann, T. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.02.004 · Cited by 133
Metabolic rivalry: circadian homeostasis and tumorigenesis
Kinouchi, K., & Sassone‐Corsi, P. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0291-9 · Cited by 133
Temporal Coordination of Carbohydrate Metabolism during Mosquito Reproduction
Hou, Y., Wang, X., Saha, T. T., Roy, S., Zhao, B., Raikhel, A. S., & Zou, Z. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005309 · Cited by 124
Structural characterization of mammalian bHLH-PAS transcription factors
Wu, D., & Rastinejad, F. (2017) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2016.09.011 · Cited by 122
The aryl hydrocarbon receptor: structure, signaling, physiology and pathology
Coumoul, X., Barouki, R., Esser, C., Haarmann‐Stemmann, T., Lawrence, B. P., Lehmann, J., Moura‐Alves, P., Murray, I. A., Opitz, C. A., Perdew, G. H., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02500-8 · Cited by 120
The complex biology of aryl hydrocarbon receptor activation in cancer and beyond
Opitz, C. A., Holfelder, P., Prentzell, M. T., & Trump, S. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115798 · Cited by 120
Regulation Is in the Air: The Relationship between Hypoxia and Epigenetics in Cancer
Camuzi, D., de Amorim, Í. S. S., Pinto, L. F. R., Trivilin, L. O., Mencalha, A. L., & Soares‐Lima, S. C. (2019) · Cells · doi:10.3390/cells8040300 · Cited by 111
Modeling the binding of diverse ligands within the Ah receptor ligand binding domain
Giani Tagliabue, S., Faber, S. C., Motta, S., Denison, M. S., & Bonati, L. (2019) · Scientific Reports · doi:10.1038/s41598-019-47138-z · Cited by 106
Hypoxia-mediated drug resistance in breast cancers
McAleese, C. E., Choudhury, C., Butcher, N. J., & Minchin, R. F. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.11.045 · Cited by 106
Nanomedicine Strategies in Conquering and Utilizing the Cancer Hypoxia Environment
Pan, Y., Liu, L., Mou, X., & Cai, Y. (2023) · ACS Nano · doi:10.1021/acsnano.3c07763 · Cited by 101
Chromatin and oxygen sensing in the context of JmjC histone demethylases
Shmakova, A., Batie, M., Druker, J., & Rocha, S. (2014) · Biochemical Journal · doi:10.1042/bj20140754 · Cited by 99
Ravenna, L., Salvatori, L., & Russo, M. A. (2016) · The FEBS Journal · doi:10.1111/febs.13572 · Cited by 97
Ouyang, L., Yan, B., Liu, Y., Mao, C., Wang, M., Liu, N., Wang, Z., Liu, S., Shi, Y., Chen, L., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0181-3 · Cited by 92
Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy
Liu, Q., Guan, C., Liu, C., Li, H., Wu, J., & Sun, C. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113861 · Cited by 92
Liu, D., Ray, B., Neavin, D. R., Zhang, J., Athreya, A. P., Biernacka, J. M., Bobo, W. V., Hall-Flavin, D. K., Skime, M. K., Zhu, H., et al. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0056-8 · Cited by 78
Wu, D., Su, X., Potluri, N., Kim, Y., & Rastinejad, F. (2016) · eLife · doi:10.7554/elife.18790 · Cited by 85
Genetic variation of clock genes and cancer risk: a field synopsis and meta-analysis
Benna, C., Helfrich‐Förster, C., Rajendran, S., Monticelli, H., Pilati, P., Nitti, D., & Mocellin, S. (2017) · Oncotarget · doi:10.18632/oncotarget.15074 · Cited by 84
Hypoxia-inducible factor 1 and its role in viral carcinogenesis
Cuninghame, S., Jackson, R., & Zehbe, I. (2014) · Virology · doi:10.1016/j.virol.2014.02.027 · Cited by 79
RETRACTED: Genomic Decoding of Neuronal Depolarization by Stimulus-Specific NPAS4 Heterodimers
Brigidi, G. S., Hayes, M. G. B., Santos, N. P. D., Hartzell, A. L., Texari, L., Lin, P.-A., Bartlett, A., Ecker, J. R., Benner, C. W., Heinz, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.09.004 · Cited by 74
RetractedLuecke-Johansson, S., Gralla, M., Rundqvist, H., Ho, J. C., Johnson, R. S., Gradin, K., & Poellinger, L. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00630-16 · Cited by 65
The aryl hydrocarbon receptor (AhR) as a breast cancer drug target
Baker, J. R., Sakoff, J. A., & McCluskey, A. (2019) · Medicinal Research Reviews · doi:10.1002/med.21645 · Cited by 73
Wei, Y., Zhao, L., He, W., Yang, J., Geng, C., Chen, Y., Liu, T., Chen, H., & Li, Y. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3674 · Cited by 71
Pharmacological blockage of the AHR-CYP1A1 axis: a call for in vivo evidence
Coelho, N. R., Pimpão, A. B., Correia, M. J., Rodrigues, T. C., Monteiro, E. C., Morelló, J., & Pereira, S. A. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02163-2 · Cited by 71
The Landscape of AhR Regulators and Coregulators to Fine-Tune AhR Functions
Gargaro, M., Scalisi, G., Manni, G., Mondanelli, G., Grohmann, U., & Fallarino, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020757 · Cited by 68
Nuclear Receptor Coactivators (NCOAs) and Corepressors (NCORs) in the Brain
Sun, Z., & Xu, Y. (2020) · Endocrinology · doi:10.1210/endocr/bqaa083 · Cited by 67
Ikuta, T., Kurosumi, M., Yatsuoka, T., & Nishimura, Y. (2016) · Experimental Cell Research · doi:10.1016/j.yexcr.2016.03.012 · Cited by 63
Moreno Roig, E., Yaromina, A., Houben, R., Groot, A. J., Dubois, L., & Vooijs, M. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00224 · Cited by 60
Yang, Y., Tang, H., Zheng, J., & Yang, K. (2022) · Translational Oncology · doi:10.1016/j.tranon.2022.101360 · Cited by 60
Vázquez-Gómez, G., Rocha‐Zavaleta, L., Rodríguez‐Sosa, M., Petrosyan, P., & Rubio-Lightbourn, J. (2018) · Toxicology Letters · doi:10.1016/j.toxlet.2018.03.012 · Cited by 60
Time to target the circadian clock for drug discovery
Sjulstok, E., Takahashi, J. S., & Green, C. B. (2022) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2022.04.009 · Cited by 61
Out of breath, out of time: interactions between HIF and circadian rhythms
O’Connell, E. J., Martinez, C.-A., Liang, Y. G., Cistulli, P. A., & Cook, K. M. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00305.2020 · Cited by 59
The Relationship between Autism Spectrum Disorder and Melatonin during Fetal Development
Jin, Y., Choi, J., Won, J., & Hong, Y. (2018) · Molecules · doi:10.3390/molecules23010198 · Cited by 52
The p160/Steroid Receptor Coactivator Family: Potent Arbiters of Uterine Physiology and Dysfunction1
Szwarc, M. M., Kommagani, R., Lessey, B. A., & Lydon, J. P. (2014) · Biology of Reproduction · doi:10.1095/biolreprod.114.125021 · Cited by 55
The inhibition of lung cancer cell migration by AhR-regulated autophagy
Tsai, C.-H., Li, C.-H., Cheng, Y., Lee, C., Liao, P.-L., Lin, C., Huang, S.-H., & Kang, J. (2017) · Scientific Reports · doi:10.1038/srep41927 · Cited by 53
Interaction between AhR and HIF-1 signaling pathways mediated by ARNT/HIF-1β
Zhang, M., Hu, Y., Yang, F., Zhang, J., Zhang, J., Yu, W., Wang, M., Lv, X., Li, J., Bai, T., et al. (2022) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-022-00564-8 · Cited by 51
Jiang, X., Wang, J., Lin, L., Du, L., Ding, Y., Zheng, F., Xie, H., Wang, Y., Hu, M., Liu, B., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02042-5 · Cited by 51
The role of circadian rhythm regulator PERs in oxidative stress, immunity, and cancer development
Zhao, B., Nepovimová, E., & Wu, Q. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02040-2 · Cited by 50
bHLH–PAS Proteins: Their Structure and Intrinsic Disorder
Kolonko, M., & Greb‐Markiewicz, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153653 · Cited by 49
Origin and functional diversification of PAS domain, a ubiquitous intracellular sensor
Xing, J., Gumerov, V. M., & Zhulin, I. B. (2023) · Science Advances · doi:10.1126/sciadv.adi4517 · Cited by 50
Lin, Q., & Yun, Z. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00039 · Cited by 47
Torres‐Machorro, A. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312855 · Cited by 46
Metabolic Implications of Circadian–HIF Crosstalk
Peek, C. B. (2020) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2020.02.008 · Cited by 45
Corrada, D., Soshilov, A. A., Denison, M. S., & Bonati, L. (2016) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1004981 · Cited by 43
“They are capable of forming dimers with one or more class I proteins and the resulting heterodimers gain the ability to bind to specific DNA sites to regulate specific target genes [2,14].”
BackgroundHIF has Biff – Crosstalk between HIF1a and the family of bHLH/PAS proteins
Button, E. L., Bersten, D. C., & Whitelaw, M. L. (2017) · Experimental Cell Research · doi:10.1016/j.yexcr.2017.03.055 · Cited by 43
Self-citationHulse, M., Caruso, L. B., Madžo, J., Tan, Y., Johnson, S., & Tempera, I. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007394 · Cited by 43
The Aryl Hydrocarbon Receptor Pathway Defines the Time Frame for Restorative Neurogenesis
Giaimo, R. D., Đurović, T., Barquin, P., Kociaj, A., Lepko, T., Aschenbroich, S., Breunig, C., Irmler, M., Cernilogar, F. M., Schotta, G., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.11.055 · Cited by 43
Li, J., Xi, W., Li, X., Sun, H., & Li, Y. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.01.042 · Cited by 42
Chen, F., Zheng, G., Qu, M., Wang, Y., Lyu, M. A., & Zhu, X. (2021) · Journal of Experimental Botany · doi:10.1093/jxb/eraa566 · Cited by 42
Glycolysis under Circadian Control
Zlacká, J., & Zeman, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222413666 · Cited by 42
Uremic toxins mediate kidney diseases: the role of aryl hydrocarbon receptor
Xie, H., Yang, N., Yu, C., & Lü, L. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00550-4 · Cited by 41
von-Hippel Lindau and Hypoxia-Inducible Factor at the Center of Renal Cell Carcinoma Biology
Shirole, N. H., & Kaelin, W. G. (2023) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2023.04.011 · Cited by 39
Pelster, B., & Egg, M. (2015) · Physiological and Biochemical Zoology · doi:10.1086/679751 · Cited by 38
Li, H. L., Gu, X. H., Li, B. J., Chen, X., Lin, H., & Xia, J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173478 · Cited by 38
Shiizaki, K., Kido, K., & Mizuta, Y. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224613 · Cited by 37
Motta, S., Callea, L., Bonati, L., & Pandini, A. (2022) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.1c01163 · Cited by 37
Huang, J., Cai, X., Ou, Y., Le, F., Zhou, Y., & Wang, Y. (2019) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.13166 · Cited by 37
Faber, S. C., Soshilov, A. A., Giani Tagliabue, S., Bonati, L., & Denison, M. S. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19092692 · Cited by 36
The AhR Signaling Mechanism: A Structural Point of View
Bonati, L., Motta, S., & Callea, L. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168296 · Cited by 37
Cryptochromes Suppress HIF1α in Muscles
Vaughan, M. E., Wallace, M., Handzlik, M. K., Chan, A. B., Metallo, C. M., & Lamia, K. A. (2020) · iScience · doi:10.1016/j.isci.2020.101338 · Cited by 36
Riedl, T., Faure‐Dupuy, S., Rolland, M., Schuehle, S., Hizir, Z., Calderazzo, S., Zhuang, X., Wettengel, J. M., Lopez, M., Barnault, R., et al. (2021) · Hepatology · doi:10.1002/hep.31902 · Cited by 36
Evolution of the HIF targeted therapy in clear cell renal cell carcinoma
Golijanin, B., Malshy, K., Khaleel, S. S., Lagos, G., Amin, A., Cheng, L., Golijanin, D., & Mega, A. E. (2023) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2023.102645 · Cited by 36
Alternaria alternata Toxins Synergistically Activate the Aryl Hydrocarbon Receptor Pathway In Vitro
Hohenbichler, J., Aichinger, G., Rychlik, M., Favero, G. D., & Marko, D. (2020) · Biomolecules · doi:10.3390/biom10071018 · Cited by 35
Modulation of HIF-2α PAS-B domain contributes to physiological responses
Feng, Z., Zou, X., Chen, Y., Wang, H., Duan, Y., & Bruick, R. K. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1810897115 · Cited by 34
Sun, X., Jing, L., Li, F., Zhang, M., Diao, X., Zhuang, J., Rastinejad, F., & Wu, D. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208804119 · Cited by 32
Targeting aryl hydrocarbon receptor to prevent cancer in barrier organs
Congues, F., Wang, P., Lee, J., Lin, D., Shahid, A., Xie, J., & Huang, Y. S. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116156 · Cited by 32
Jeschke, U., Zhang, X., Kühn, C., Jalaguier, S., Colinge, J., Pfender, K., Mayr, D. C., Ditsch, N. C., Harbeck, N., Mahner, S., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20051016 · Cited by 32
Jóźwiak, P., Ciesielski, P., Zaczek, A., Lipińska, A., Pomorski, L., Wieczorek, M., Bryś, M., Forma, E., & Krześlak, A. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0388-y · Cited by 31
“tion but they have unique tissue and cell type distributions [2, 3, 25].”
When AHR signaling pathways meet viral infections
Hu, J., Ding, Y., Liu, W., & Liu, S. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01058-8 · Cited by 31
Indole-3-pyruvic acid alleviates rheumatoid arthritis via the aryl hydrocarbon receptor pathway
Huang, T., Cheng, L., Jiang, Y. J., Zhang, L., & Qian, L. (2023) · Annals of Translational Medicine · doi:10.21037/atm-23-1074 · Cited by 32
Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis
Wang, D., Zhang, X., Lu, Y., Wang, X., & Zhu, L. (2018) · Pathology - Research and Practice · doi:10.1016/j.prp.2018.09.007 · Cited by 31
Yuan, P., Wang, S., Zhou, F., Wan, S., Yang, Y., Huang, X., Zhang, Z., Zhu, Y. L., Zhang, H., & Xing, J. (2014) · Cancer Science · doi:10.1111/cas.12428 · Cited by 30
Luo, Y.-H., Kuo, Y.-C., Tsai, M., Ho, C.-C., Tsai, H.-T., Hsu, C.-Y., Chen, Y., & Lin, P. (2017) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2017.03.019 · Cited by 29
Porel, P., Bala, K., & Aran, K. R. (2024) · Inflammopharmacology · doi:10.1007/s10787-024-01585-x · Cited by 28
Targeting the NCOA3-SP1-TERT axis for tumor growth in hepatocellular carcinoma
Li, W., Yan, Y., Zheng, Z., Zhu, Q., Qian, L., Sui, S., Luo, M., Chen, M., Li, Y., Hua, Y., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03218-x · Cited by 28
Regulation of Intestinal Stem Cell Stemness by the Aryl Hydrocarbon Receptor and Its Ligands
Wisniewski, P. J., Nagarkatti, M., & Nagarkatti, P. S. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.638725 · Cited by 28
Joshi, A., Hossain, E., & Elferink, C. J. (2017) · Molecular Pharmacology · doi:10.1124/mol.117.108878 · Cited by 28
Circadian Rhythm Disruption and Subsequent Neurological Disorders in Night-Shift Workers
Jin, Y., Hur, T., & Hong, Y. (2017) · Journal of Lifestyle Medicine · doi:10.15280/jlm.2017.7.2.45 · Cited by 29
Veith, A. C., Aram, B. B., Jiang, W., Wang, L., Zhou, G., Jefcoate, C. R. E., Couroucli, X. I., Lingappan, K., & Moorthy, B. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy154 · Cited by 28
Kwapiszewska, G., Johansen, A. K. Z., Gomez‐Arroyo, J. G., & Voelkel, N. F. (2019) · Circulation Research · doi:10.1161/circresaha.119.315054 · Cited by 28
Bonati, L., Corrada, D., Giani Tagliabue, S., & Motta, S. (2017) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2017.01.011 · Cited by 27
Associations of clock genes polymorphisms with soft tissue sarcoma susceptibility and prognosis
Benna, C., Rajendran, S., Spiro, G., Tropea, S., Fiore, P. D., Rossi, C. R., & Mocellin, S. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1715-0 · Cited by 27
Zablon, H. A., Ko, C., & Puga, A. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab050 · Cited by 27
Decoding Allosteric Control in Hypoxia-Inducible Factors
Zhuang, J., Shang, Q., Rastinejad, F., & Wu, D. (2023) · Journal of Molecular Biology · doi:10.1016/j.jmb.2023.168352 · Cited by 26
Li, W., Liang, Y. J., Yang, B., Sun, H., & Wu, W. (2015) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12905 · Cited by 26
Metadata
- Authors
- Bersten, D. C., Sullivan, A. E., Peet, D. J., & Whitelaw, M. L.
- Affiliations
- The University of Adelaide (AU)
- Corresponding author
- Whitelaw, Murray L.
- Venue
- Nature Reviews Cancer
- Published
- 2013-11-22
- Volume
- 13
- Issue
- 12
- Pages
- 827-841
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2011946509
- Cited by
- 267
- References
- 181
- Citations by year
- 2026: 18 · 2025: 18 · 2024: 25 · 2023: 27 · 2022: 25 · 2021: 26 · 2020: 20 · 2019: 17 · 2018: 28 · 2017: 20 · 2016: 19 · 2015: 12 · 2014: 12
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- bHLH-PAS proteins, helix-loop-helix transcription factors, PAS domain, heterodimeric transcription factors, oncometabolites, cancer metabolism, hypoxia signaling, circadian rhythm, environmental pollutants, protein structure, drug discovery
- MeSH terms
- Animals, Circadian Rhythm, Humans, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Basic Helix-Loop-Helix Proteins, CLOCK Proteins, Circadian Clocks
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.